Ovid Therapeutics (OVID) Exchange Rate Effect (2026)
Ovid Therapeutics' (OVID) quarterly Exchange Rate Effect came in at -$4000.0 in Q2 2026, up 96.72% quarter-over-quarter from -$122000.0 in Q1 2026.
Powered by 
Analysis
Ovid Therapeutics (OVID) Exchange Rate Effect (2026) Analysis & Trends
Ovid Therapeutics (OVID) has reported Exchange Rate Effect for 1 consecutive years, with -$4000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect changed N/A year-over-year to -$4000.0; the trailing twelve-month figure through Jun 2026 stood at -$126000.0 (changed N/A YoY), and the FY2025 full-year result was -$167000.0, changed N/A from the prior year.
- Exchange Rate Effect advanced to -$4000.0 in Q2 2026 per OVID's latest filing, from -$122000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at -$4000.0 in Q2 2026 and bottomed at -$122000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 19.84 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -84,000.00 |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | -4,000.00 |